Skip to content

Startup & venture capital news

bit.bio raises USD 25m Series D

Fresh capital supports programmable human cell models

By /

LinkedInX
bit.bio: bit.bio raises USD 25m Series D

Cambridge based bit.bio announced a USD 25 million Series D on 4 November 2026 from existing investor M and G Investments and biotechnology entrepreneur Jonathan Milner. No lead was stated. The company uses its cell programming technology to manufacture defined human cell models for research and drug development. Researchers use the cells to study disease biology, test compounds and build more consistent experiments. bit.bio said demand for its products had reached record levels. The financing will expand product development, manufacturing and commercial reach as the company adds cell types and works with pharmaceutical and biotechnology customers.

Keep reading

More Funding

All stories